BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8231399)

  • 1. [Molecular biology studies in chronic myeloid leukemia].
    Cervantes F
    Med Clin (Barc); 1993 Oct; 101(14):538-40. PubMed ID: 8231399
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Philadelphia chromosome 30 years later].
    Lisker R
    Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
    Medeiros BC; Markovic V; Kamel-Reid S; Lipton JH
    Cancer Genet Cytogenet; 2007 Feb; 173(1):83-4. PubMed ID: 17284377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
    Tanzer J
    Rev Prat; 1988 Jun; 38(18):1210-6. PubMed ID: 3175491
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome-negative, bcr/abl-positive chronic myelogenous leukemia.
    Inokuchi K; Dan K
    J Nippon Med Sch; 2001 Aug; 68(4):292-3. PubMed ID: 11505275
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular analysis of Philadelphia chromosome positive leukaemias.
    Young BD
    Br J Cancer Suppl; 1988 Dec; 9():58-61. PubMed ID: 3076066
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia.
    Zanella I; Rossi G; Finazzi D; Capucci A; Albertini A; Cariani E
    Haematologica; 2001 Mar; 86(3):318-9. PubMed ID: 11255281
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
    Haigh S; Cuthbert G
    Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The molecular biology diagnosis of neoplastic blood diseases].
    Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
    Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotype analysis in chronic myelogenous leukemia. A three-year experience at the American University of Beirut Medical Center (AUBMC).
    el-Assaad W; al-Oreibi G; Zahed L
    J Med Liban; 1998; 46(1):16-9. PubMed ID: 9795517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting.
    Chang H; Sutherland R; Nayar R; Li D; Kamel-Reid S; Mile MA; Messner H; Lipton J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):146-8. PubMed ID: 15262435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
    Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myeloid leukemia from basics to bedside.
    Thijsen S; Schuurhuis G; van Oostveen J; Ossenkoppele G
    Leukemia; 1999 Nov; 13(11):1646-74. PubMed ID: 10557038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic profile of chronic myeloid leukemias.
    Jacob RT; Gayathri K; Surath A; Rao DR
    Indian J Cancer; 2002 Jun; 39(2):61-5. PubMed ID: 12789726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.
    Karti S; Yilmaz M; Sonmez M; Akdogan R; Ersoz S; Ucar F; Ovali E
    J Exp Clin Cancer Res; 2003 Jun; 22(2):341-2. PubMed ID: 12866588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.